Supreme Court justices appeared divided over Purdue Pharma’s bankruptcy deal Monday, questioning whether it can immunize the Sackler family from civil lawsuits for their role in the opioid crisis. …
Supreme Court justices appeared divided over Purdue Pharma’s bankruptcy deal Monday, questioning whether it can immunize the Sackler family from civil lawsuits for their role in the opioid crisis.
An overwhelming majority voted to approve Purdue Pharma’s settlement, but the Supreme Court on Monday wrestled with objections lodged by the Biden administration and a relatively small group of creditors concerning the liability releases for the Sacklers, who previously controlled the company.
During a nearly two-hour argument that transcended ideological lines, several justices raised concerns about how the administration’s position would effectively unravel the settlement.
In 2019, OxyContin maker Purdue Pharma filed for bankruptcy as it faced a flood of lawsuits alleging the addictive painkiller’s aggressive marketing fueled the opioid epidemic.
That type of release has served as a key tactic in other mass tort bankruptcy cases, including abuse lawsuits against the Catholic Church.
The contributions from the Sacklers and the company’s remaining assets would be used to pay victims and fund efforts to combat the opioid crisis.
The original article contains 677 words, the summary contains 167 words. Saved 75%. I’m a bot and I’m open source!
This is the best summary I could come up with:
Supreme Court justices appeared divided over Purdue Pharma’s bankruptcy deal Monday, questioning whether it can immunize the Sackler family from civil lawsuits for their role in the opioid crisis.
An overwhelming majority voted to approve Purdue Pharma’s settlement, but the Supreme Court on Monday wrestled with objections lodged by the Biden administration and a relatively small group of creditors concerning the liability releases for the Sacklers, who previously controlled the company.
During a nearly two-hour argument that transcended ideological lines, several justices raised concerns about how the administration’s position would effectively unravel the settlement.
In 2019, OxyContin maker Purdue Pharma filed for bankruptcy as it faced a flood of lawsuits alleging the addictive painkiller’s aggressive marketing fueled the opioid epidemic.
That type of release has served as a key tactic in other mass tort bankruptcy cases, including abuse lawsuits against the Catholic Church.
The contributions from the Sacklers and the company’s remaining assets would be used to pay victims and fund efforts to combat the opioid crisis.
The original article contains 677 words, the summary contains 167 words. Saved 75%. I’m a bot and I’m open source!